Prospective Study of White Blood Cells
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorQuell Therapeutics Limited
About this trial
The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Volunteers willing to provide white blood cells for research.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
White blood cell and blood collection
Other interventionMononucleocytes will be collected via apheresis
Treatment groups
10 Participants
are divided into 1 treatment groupGroup A: Specimen collection to support development of engineering Treg1 intervention
Trial outcomes
Primary outcomes
1
WBC characterisation to support the development of engineered regulatory T cells.
number, type and function of white blood cells in healthy controls and in patients
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov